As global markets experience strong gains amid geopolitical de-escalation and positive economic data, investors are increasingly focused on identifying opportunities that may be trading below their estimated value. In this environment, a good stock is often characterized by solid fundamentals and growth potential that the market has yet to fully recognize.
Top 10 Undervalued Stocks Based On Cash Flows
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| SoftwareOne Holding (SWX:SWON) |
CHF7.04 |
CHF13.93 |
49.5% |
| MicroPort Scientific (SEHK:853) |
HK$9.20 |
HK$18.13 |
49.3% |
| Metriks AI. Società Benefit (BIT:MTK) |
€3.56 |
€7.04 |
49.5% |
| Mare Group (BIT:MARE) |
€3.37 |
€6.65 |
49.3% |
| Lum Chang Creations (Catalist:LCC) |
SGD0.99 |
SGD1.96 |
49.5% |
| Eltel (OM:ELTEL) |
SEK9.58 |
SEK19.12 |
49.9% |
| cyan (XTRA:CYR) |
€2.02 |
€4.01 |
49.6% |
| Canatu Oyj (HLSE:CANATU) |
€7.90 |
€15.70 |
49.7% |
| CAG Group (OM:CAG) |
SEK111.00 |
SEK219.36 |
49.4% |
| B&S Group (ENXTAM:BSGR) |
€5.85 |
€11.66 |
49.8% |
Let's uncover some gems from our specialized screener.
Turkiye Garanti Bankasi
Overview:Turkiye Garanti Bankasi A.S. offers a range of banking products and services in Turkey, with a market cap of TRY585.48 billion.
Operations:The company's revenue segments include Retail Banking at TRY233.75 billion, Corporate Banking at TRY207.92 billion, and Investment Banking at -TRY165.35 billion.
Estimated Discount To Fair Value:10.9%
Turkiye Garanti Bankasi is trading below its estimated future cash flow value of TRY156.4 at TRY139.4, offering potential value for investors focused on cash flows. The bank's revenue growth forecast of 23.2% annually surpasses the Turkish market average, yet earnings growth lags behind the market at 20.3%. Despite a high return on equity forecast and good relative valuation to peers, concerns include an unstable dividend history and a high level of non-performing loans (3%). Recent debt redemptions and issuances indicate active capital management but ongoing regulatory scrutiny poses risks.
Dr. Soliman Abdel Kader Fakeeh Hospital
Overview:Dr. Soliman Abdel Kader Fakeeh Hospital Company, along with its subsidiaries, operates hospitals, clinics, and medical educational and training centers in Saudi Arabia with a market cap of SAR8.30 billion.
Operations:The company's revenue segments include Medical Services at SAR2.87 billion, Education at SAR125.83 million, and Trading & Retail at SAR439.34 million.
Estimated Discount To Fair Value:33.2%
Dr. Soliman Abdel Kader Fakeeh Hospital is trading at SAR36, significantly below its estimated future cash flow value of SAR53.91, presenting a potential opportunity for investors focused on undervalued stocks based on cash flows. The company's earnings are forecast to grow 21% annually, outpacing the Saudi Arabian market average of 7.2%. Despite this growth, recent earnings reports show only a slight increase in net income year over year, highlighting potential profitability challenges ahead.
Guangdong Songfa CeramicsLtd
Overview:Guangdong Songfa Ceramics Co., Ltd. produces and sells ceramic products both in China and internationally, with a market cap of CN¥137.14 billion.
Operations:Guangdong Songfa Ceramics Co., Ltd. generates its revenue from the production and sale of ceramic products within China and to international markets.
Estimated Discount To Fair Value:18.2%
Guangdong Songfa Ceramics is trading at CN¥142.48, below its estimated future cash flow value of CN¥174.11, suggesting undervaluation based on cash flows. The company's earnings surged over 1000% last year and are expected to grow 65.7% annually, surpassing the Chinese market average of 27%. However, despite impressive revenue growth forecasts of 37.6%, debt coverage by operating cash flow remains a concern alongside recent shareholder dilution impacting financial stability.
Taking Advantage
-
Access the full spectrum of 412 Undervalued Global Stocks Based On Cash Flows by clicking on this link.
-
Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
-
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Looking For Alternative Opportunities?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include IBSE:GARAN SASE:4017 and SHSE:603268.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
